These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22480182)

  • 1. Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: synthesis, structure-activity relationships, and pharmacokinetics.
    Ndungu JM; Krumm SA; Yan D; Arrendale RF; Reddy GP; Evers T; Howard R; Natchus MG; Saindane MT; Liotta DC; Plemper RK; Snyder JP; Sun A
    J Med Chem; 2012 May; 55(9):4220-30. PubMed ID: 22480182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity.
    Cox RM; Sourimant J; Govindarajan M; Natchus MG; Plemper RK
    PLoS Pathog; 2021 Feb; 17(2):e1009371. PubMed ID: 33621266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex.
    Sun A; Yoon JJ; Yin Y; Prussia A; Yang Y; Min J; Plemper RK; Snyder JP
    J Med Chem; 2008 Jul; 51(13):3731-41. PubMed ID: 18529043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex activity: Synthesis and in vitro evaluation.
    Sun A; Chandrakumar N; Yoon JJ; Plemper RK; Snyder JP
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5199-203. PubMed ID: 17643302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity.
    White LK; Yoon JJ; Lee JK; Sun A; Du Y; Fu H; Snyder JP; Plemper RK
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2293-303. PubMed ID: 17470652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target analysis of the experimental measles therapeutic AS-136A.
    Yoon JJ; Krumm SA; Ndungu JM; Hoffman V; Bankamp B; Rota PA; Sun A; Snyder JP; Plemper RK
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3860-70. PubMed ID: 19528268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding.
    Wittwer K; Anderson DE; Pfeffermann K; Cox RM; Wolf JD; Santibanez S; Mankertz A; Plesker R; Sticher ZM; Kolkykhalov AA; Natchus MG; Pfaller CK; Plemper RK; von Messling V
    Nat Commun; 2021 Sep; 12(1):5233. PubMed ID: 34475387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model.
    Chen CM; He Y; Lu L; Lim HB; Tripathi RL; Middleton T; Hernandez LE; Beno DW; Long MA; Kati WM; Bosse TD; Larson DP; Wagner R; Lanford RE; Kohlbrenner WE; Kempf DJ; Pilot-Matias TJ; Molla A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4290-6. PubMed ID: 17908950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.
    Li H; Tatlock J; Linton A; Gonzalez J; Jewell T; Patel L; Ludlum S; Drowns M; Rahavendran SV; Skor H; Hunter R; Shi ST; Herlihy KJ; Parge H; Hickey M; Yu X; Chau F; Nonomiya J; Lewis C
    J Med Chem; 2009 Mar; 52(5):1255-8. PubMed ID: 19209845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
    Randolph JT; Flentge CA; Huang PP; Hutchinson DK; Klein LL; Lim HB; Mondal R; Reisch T; Montgomery DA; Jiang WW; Masse SV; Hernandez LE; Henry RF; Liu Y; Koev G; Kati WM; Stewart KD; Beno DW; Molla A; Kempf DJ
    J Med Chem; 2009 May; 52(10):3174-83. PubMed ID: 19402666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.
    Klumpp K; Kalayanov G; Ma H; Le Pogam S; Leveque V; Jiang WR; Inocencio N; De Witte A; Rajyaguru S; Tai E; Chanda S; Irwin MR; Sund C; Winqist A; Maltseva T; Eriksson S; Usova E; Smith M; Alker A; Najera I; Cammack N; Martin JA; Johansson NG; Smith DB
    J Biol Chem; 2008 Jan; 283(4):2167-75. PubMed ID: 18003608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex.
    Cox RM; Toots M; Yoon JJ; Sourimant J; Ludeke B; Fearns R; Bourque E; Patti J; Lee E; Vernachio J; Plemper RK
    J Biol Chem; 2018 Oct; 293(43):16761-16777. PubMed ID: 30206124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.
    Shi ST; Herlihy KJ; Graham JP; Nonomiya J; Rahavendran SV; Skor H; Irvine R; Binford S; Tatlock J; Li H; Gonzalez J; Linton A; Patick AK; Lewis C
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2544-52. PubMed ID: 19307358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives.
    Nichols DB; Fournet G; Gurukumar KR; Basu A; Lee JC; Sakamoto N; Kozielski F; Musmuca I; Joseph B; Ragno R; Kaushik-Basu N
    Eur J Med Chem; 2012 Mar; 49():191-9. PubMed ID: 22280819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally efficacious broad-spectrum allosteric inhibitor of paramyxovirus polymerase.
    Cox RM; Sourimant J; Toots M; Yoon JJ; Ikegame S; Govindarajan M; Watkinson RE; Thibault P; Makhsous N; Lin MJ; Marengo JR; Sticher Z; Kolykhalov AA; Natchus MG; Greninger AL; Lee B; Plemper RK
    Nat Microbiol; 2020 Oct; 5(10):1232-1246. PubMed ID: 32661315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors.
    Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X
    Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles Virus Fusion Protein: Structure, Function and Inhibition.
    Plattet P; Alves L; Herren M; Aguilar HC
    Viruses; 2016 Apr; 8(4):112. PubMed ID: 27110811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Haudecoeur R; Ahmed-Belkacem A; Yi W; Fortuné A; Brillet R; Belle C; Nicolle E; Pallier C; Pawlotsky JM; Boumendjel A
    J Med Chem; 2011 Aug; 54(15):5395-402. PubMed ID: 21699179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase.
    Hwang SH; Wagner KM; Morisseau C; Liu JY; Dong H; Wecksler AT; Hammock BD
    J Med Chem; 2011 Apr; 54(8):3037-50. PubMed ID: 21434686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.